Abstract
Endometriosis is an inflammatory disease characterized by the presence of endometrial glandular epithelial and stromal cells growing in the extra-uterine environment. The disease affects: ovarian function, oocyte quality, embryo development and implantation, and uterine function resulting in infertility or spontaneous pregnancy loss. Even though the world’s prevalence is above 10 %, an effective treatment has not yet been found. New pharmacological approaches have been designed and patented that could serve as future therapies for this disease.
Keywords: Androgens, coagulation, endometriosis, fertility, GnHR, inflammation, progesterone, signal transduction.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Perspectives of New Therapies for Endometriosis
Volume: 6 Issue: 3
Author(s): Jenny V. Garmendia and Juan B. De Sanctis
Affiliation:
Keywords: Androgens, coagulation, endometriosis, fertility, GnHR, inflammation, progesterone, signal transduction.
Abstract: Endometriosis is an inflammatory disease characterized by the presence of endometrial glandular epithelial and stromal cells growing in the extra-uterine environment. The disease affects: ovarian function, oocyte quality, embryo development and implantation, and uterine function resulting in infertility or spontaneous pregnancy loss. Even though the world’s prevalence is above 10 %, an effective treatment has not yet been found. New pharmacological approaches have been designed and patented that could serve as future therapies for this disease.
Export Options
About this article
Cite this article as:
V. Garmendia Jenny and B. De Sanctis Juan, Perspectives of New Therapies for Endometriosis, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2012; 6 (3) . https://dx.doi.org/10.2174/187221412802481702
DOI https://dx.doi.org/10.2174/187221412802481702 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry Studying Adsorption and Cellular Toxicity of Boron Nitride Nanostructure versus Melphalan Anti-ovarian Cancer Drug
Current Molecular Medicine Isomers of 4-[<sup>18</sup>F]fluoro-proline: Radiosynthesis, Biological Evaluation and Results in Humans Using PET
Current Radiopharmaceuticals Wnt Signaling and Cell-Matrix Adhesion
Current Molecular Medicine Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment
Current Drug Targets The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro
Anti-Cancer Agents in Medicinal Chemistry Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets AKT Signaling in Regulating Angiogenesis
Current Cancer Drug Targets 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis
Anti-Cancer Agents in Medicinal Chemistry DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Biomarkers Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Review: Recent Clinical Trials in Epigenetic Therapy
Reviews on Recent Clinical Trials Formulation Development of Folic Acid Conjugated PLGA Nanoparticles for Improved Cytotoxicity of Caffeic Acid Phenethyl Ester
Pharmaceutical Nanotechnology